12/17
08:05 am
evax
Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity [Yahoo! Finance]
High
Report
Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity [Yahoo! Finance]
12/17
08:00 am
evax
Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity
High
Report
Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity
12/12
08:17 am
evax
Evaxion establishes new AI-derived precision cancer vaccine concept [Yahoo! Finance]
Low
Report
Evaxion establishes new AI-derived precision cancer vaccine concept [Yahoo! Finance]
12/12
08:00 am
evax
Evaxion establishes new AI-derived precision cancer vaccine concept
Medium
Report
Evaxion establishes new AI-derived precision cancer vaccine concept
12/9
08:15 am
evax
Evaxion announces 2025 milestones reflecting continued strong strategy execution [Yahoo! Finance]
Medium
Report
Evaxion announces 2025 milestones reflecting continued strong strategy execution [Yahoo! Finance]
12/9
08:00 am
evax
Evaxion announces 2025 milestones reflecting continued strong strategy execution
Medium
Report
Evaxion announces 2025 milestones reflecting continued strong strategy execution
12/2
08:07 am
evax
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress [Yahoo! Finance]
Medium
Report
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress [Yahoo! Finance]
12/2
08:00 am
evax
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress
Medium
Report
Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress
11/13
08:00 am
evax
Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing
High
Report
Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing
11/12
08:00 am
evax
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
High
Report
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
11/1
08:15 am
evax
Evaxion Biotech A/S (NASDAQ: EVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Medium
Report
Evaxion Biotech A/S (NASDAQ: EVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
10/31
08:00 am
evax
Evaxion announces business update and third quarter 2024 financial results
Medium
Report
Evaxion announces business update and third quarter 2024 financial results
10/28
08:00 am
evax
Evaxion to announce business update and third quarter 2024 financial results on October 31
Low
Report
Evaxion to announce business update and third quarter 2024 financial results on October 31
10/11
02:09 pm
evax
OTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCR [Yahoo! Finance]
Medium
Report
OTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCR [Yahoo! Finance]
10/9
08:00 am
evax
Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
Medium
Report
Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
10/3
08:00 am
evax
Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform
Low
Report
Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform